Psoriasis and Cannabis
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The PlaquePsoriasis.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- The Psoriasis Association (2018) The Psoriasis Association Magazine. Autumn 2018. Northampton.
- Kozela E, Juknat A, Gao F, et al. (2016) Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells J Neuroinflammation. 2016; 13: 136. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891926/ accessed 23/03/2019
- Giacoppo S, Galuppo M, Pollastro F, et al. (2015) A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitisDaru. 2015; 23: 48. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618347/ Daru. 2015; 23: 48. accessed 23/03/2019
- Hammell D, Zhang L, Ma F, et al (2016) Transdermal cannabidiol reduces inflammation and pain-related behaviors in a rat model of arthritis Eur J Pain. 20(6): 936–948. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/ accessed 23/03/2019
- Karmaus, P, Wagner, J, Harkema J et al. (2013) Cannabidiol (CBD) Enhances Lipopolysaccharide (LPS)-Induced Pulmonary Inflammation in C57BL/6 Mice J Immunotoxicol 10(3): 321–328. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632657/ accessed 23/03/2019
- FDA (2019) Questions and Answers on dietary supplements https://www.fda.gov/food/dietarysupplements/usingdietarysupplements/ucm480069.htm#FDA_role accessed 23/03/2019